Howard Weisman

Howard Weisman

Mr. Weisman is an accomplished entrepreneur in the life sciences industry. Mr. Weisman is currently the CEO of Seventh Sense Biosystems, a health technology company developing a breakthrough painless diagnostic blood collection platform. Prior to joining Seventh Sense, he was the founder, chairman, and CEO of EKR Therapeutics, a specialty pharmaceutical company focused on the hospital critical care market. He also co-founded ESP Pharma, where he served as a director as well as the company’s president and chief operating officer until its sale to PDL Biopharma in 2005.

Mr. Weisman began his career in sales and marketing at Merck & Co., later moving to Parke-Davis where he launched that company’s diabetes franchise in 1997. He graduated with a BA in chemistry from Rutgers University.

Management Team